Schedule for Rating Disabilities: The Cardiovascular System, 62095-62096 [2021-24419]
Download as PDF
Federal Register / Vol. 86, No. 214 / Tuesday, November 9, 2021 / Rules and Regulations
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
33 CFR Part 100
[Docket No. USCG–2021–0770]
Special Local Regulation; Marine
Events Within the Eleventh Coast
Guard District-San Diego Fall Classic
Dated: November 4, 2021.
T.J. Barelli,
Captain, U.S. Coast Guard, Captain of the
Port San Diego.
Coast Guard, Department of
Homeland Security (DHS).
ACTION: Notification of enforcement of
regulation.
AGENCY:
[FR Doc. 2021–24515 Filed 11–8–21; 8:45 am]
The Coast Guard will enforce
the special local regulation on the
waters of Mission Bay, San Diego,
California, during the San Diego Fall
Classic on November 14, 2021. This
special local regulation is necessary to
provide for the safety of the
participants, crew, sponsor vessels of
the rowing event, and general users of
the waterway. During the enforcement
period, persons and vessels are
prohibited from entering into, transiting
through, or anchoring within this
regulated area unless authorized by the
Captain of the Port, or his designated
representative.
SUMMARY:
The regulations in 33 CFR
100.1101 for the location described in
Table 1 to § 100.1101, Item No. 1, will
be enforced from 5:30 a.m. until 12:30
p.m. on November 14, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have questions about this
notification of enforcement, call or
email Lieutenant Commander John
Santorum, Waterways Management,
U.S. Coast Guard Sector, San Diego, CA;
telephone (619) 278–7656, email
MarineEventsSD@uscg.mil.
SUPPLEMENTARY INFORMATION: The Coast
Guard will enforce the special local
regulations in 33 CFR 100.1101 for the
location identified in Table 1 to
§ 100.1101, Item No. 1, from 5:30 a.m.
through 12:30 p.m. on November 14,
2021 for the San Diego Fall Classic in
Mission Bay, San Diego, CA. This action
is being taken to provide for the safety
of life on navigable waterways during
the rowing event. Our regulation for
recurring marine events in the San
Diego Captain of the Port Zone,
§ 100.1101, Table 1 to § 100.1101, Item
No. 1, specifies the location of the
regulated area for the San Diego Fall
Classic, which encompasses portions of
Mission Bay. Under the provisions of
§ 100.1101, persons and vessels are
prohibited from entering into, transiting
through, or anchoring within this
regulated area unless authorized by the
jspears on DSK121TN23PROD with RULES1
DATES:
VerDate Sep<11>2014
16:01 Nov 08, 2021
Jkt 256001
Captain of the Port, or his designated
representative. The Coast Guard may be
assisted by other Federal, State, or local
law enforcement agencies in enforcing
this regulation.
In addition to this document in the
Federal Register, the Coast Guard will
provide the maritime community with
advance notification of this enforcement
period via the Local Notice to Mariners
and marine information broadcasts.
BILLING CODE 9110–04–P
DEPARTMENT OF VETERANS
AFFAIRS
38 CFR Part 4
RIN 2900–AQ67
Schedule for Rating Disabilities: The
Cardiovascular System
Department of Veterans Affairs.
Final rule; correction.
AGENCY:
ACTION:
On September 30, 2021, the
Department of Veterans Affairs (VA)
published in the Federal Register a final
rule that amended the portion of the VA
Schedule for Rating Disabilities
(‘‘VASRD’’ or ‘‘rating schedule’’) that
addresses the cardiovascular system.
This correction addresses the
instructions for evaluating peripheral
arterial disease in the published final
rule and corrects another minor
technical error.
DATES: This correction is effective
November 14, 2021.
FOR FURTHER INFORMATION CONTACT: Gary
Reynolds, M.D., VASRD Program
Management Office (210),
Compensation Service, Veterans
Benefits Administration, Department of
Veterans Affairs, 810 Vermont Avenue
NW, Washington, DC 20420, (202) 461–
9700. (This is not a toll-free telephone
number.)
SUPPLEMENTARY INFORMATION: VA is
correcting its final rule, ‘‘RIN 2900–
AQ67, Schedule for Rating Disabilities:
The Cardiovascular System’’, that was
published on September 30, 2021, in the
Federal Register at 86 FR 54089. The
error is with new Note (2) for diagnostic
code (DC) 7114 peripheral arterial
disease which fails to identify which of
the four tests are necessary before an
evaluation can be assigned. In the
proposed rule, VA identified two major
shortcomings in the rating criteria for
DC 7114 that were addressed by creating
SUMMARY:
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
62095
evaluation criteria that use the ankle/
brachial index (ABI), ankle pressure
(AP), toe pressure (TP) and
transcutaneous oximetry (TcPO2) to
describe four different levels of
impairment. See 84 FR 37594, 37599
(Aug. 1, 2019). New Note (2) instructed
raters to select the highest impairment
value of ABI, AP, TP, or TcPO2 for
evaluation when rating a condition
under DC 7114. Upon further
consideration, we believe the note could
be misconstrued as requiring medical
examiners to conduct all four tests. This
is inconsistent with our intent, which
was to provide examiners with multiple
options in the event that ABI was
unreliable due to non-compressible
arteries. To address this issue, we are
correcting new Note (2) to read, ‘‘If AP,
TP, and TcPO2 testing are not of record,
evaluate based on ABI unless the
examiner states that an AP, TP, or TcPO2
test is needed in a particular case
because ABI does not sufficiently reflect
the severity of the veteran’s peripheral
arterial disease. In all other cases,
evaluate based on the test that provides
the highest impairment value.’’ This
correction serves two purposes: (1) It
reflects VA’s intent that although ABI
should be the primary testing by which
conditions should be rated under DC
7114, raters should request AP, TP, or
TcPO2 testing when the record reflects
that an examiner believes ABI testing
does not sufficiently reflect a veteran’s
level of impairment, and (2) when
multiple tests are of record, it allows the
rater to select the test result that would
grant the veteran the highest evaluation.
Additionally, VA is fixing a technical
error with the section heading for 38
CFR 4.100 to ensure that it is applicable
to all diagnostic codes that could use
the general rating formula for diseases of
the heart in its evaluation criteria, such
as DCs 7009 and 7110.
Correction
In FR Rule Doc. No. 2021–19998,
published September 30, 2021, at 86 FR
54089, make the following corrections:
§ 4.100
[Corrected]
1. On page 54093, at the top of the
third column, remove the section
heading ‘‘§ 4.100 Application of the
evaluation criteria for diagnostic codes
7000–7007, 7011, and 7015–7020.’’ and
add in its place ‘‘§ 4.100 Application of
the general rating formula for diseases of
the heart.’’
■
2. On page 54095, in § 4.104, correct
Note (2) in the entry for diagnostic code
7114 ‘‘Peripheral arterial disease’’ to
read as follows:
■
E:\FR\FM\09NOR1.SGM
09NOR1
62096
Federal Register / Vol. 86, No. 214 / Tuesday, November 9, 2021 / Rules and Regulations
§ 4.104 Schedule of ratings—
cardiovascular system.
*
*
*
*
*
DISEASES OF THE HEART
Rating
7114
*
*
Peripheral arterial disease:
*
*
*
*
*
*
*
*
*
*
Note (2): If AP, TP, and TcPO2 testing are not of record, evaluate based on ABI unless the examiner states that an AP, TP, or
TcPO2 test is needed in a particular case because ABI does not sufficiently reflect the severity of the veteran’s peripheral arterial disease. In all other cases, evaluate based on the test that provides the highest impairment value.
*
*
*
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy
& Management, Office of the Secretary,
Department of Veterans Affairs.
[FR Doc. 2021–24419 Filed 11–8–21; 8:45 am]
BILLING CODE 8320–01–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 52
[EPA–R10–OAR–2020–0648; FRL–8787–02–
R10]
Air Plan Approval; AK; Eagle River
Second 10-Year PM10 Limited
Maintenance Plan
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
The Environmental Protection
Agency (EPA) is approving the Eagle
River, Alaska (AK) limited maintenance
plan (LMP) submitted on November 10,
2020, by the Alaska Department of
Environmental Conservation (ADEC or
‘‘the State’’). This plan addresses the
second 10-year maintenance period after
redesignation for particulate matter with
an aerodynamic diameter less than or
equal to a nominal 10 micrometers
(PM10). The plan relies upon control
measures contained in the first 10-year
maintenance plan and the
determination that the Eagle River area
currently monitors PM10 levels well
below the PM10 National Ambient Air
Quality Standard (NAAQS or ‘‘the
standard’’). The EPA is approving
Alaska’s LMP as meeting Clean Air Act
(CAA) requirements.
DATES: This final rule is effective
December 9, 2021.
ADDRESSES: The EPA has established a
docket for this action under Docket ID
No. EPA–R10–OAR–2020–0648. All
documents in the docket are listed on
jspears on DSK121TN23PROD with RULES1
SUMMARY:
VerDate Sep<11>2014
16:01 Nov 08, 2021
Jkt 256001
*
*
the https://www.regulations.gov
website. Although listed in the index,
some information is not publicly
available, e.g., Confidential Business
Information or other information the
disclosure of which is restricted by
statute. Certain other material, such as
copyrighted material, is not placed on
the internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available at https://
www.regulations.gov, or please contact
the person listed in the FOR FURTHER
INFORMATION CONTACT section for
additional availability information.
FOR FURTHER INFORMATION CONTACT:
Christi Duboiski, EPA Region 10, 1200
Sixth Avenue (Suite 155), Seattle, WA
98101, at (360) 753–9081, or
duboiski.christi@epa.gov.
SUPPLEMENTARY INFORMATION:
Throughout this document wherever
‘‘we’’ or ‘‘our’’ is used, it refers to the
EPA.
I. Background
On November 10, 2020, ADEC
submitted to the EPA for approval a
second 10-year PM10 LMP for Eagle
River. The SIP revision, State effective
November 7, 2020, fulfills the second
10-year planning requirement of CAA
section 175A(b) to ensure PM10 NAAQS
compliance through 2033. The Eagle
River area has been meeting the PM10
standard for multiple years and was
redesignated to attainment on March 8,
2013 with an approved 10-year PM10
maintenance plan. The area currently
monitors PM10 levels well below the
PM10 NAAQS.
We proposed to approve the Eagle
River second 10-year LMP on September
2, 2021 (86 FR 49278). The reasons for
our approval are included in that
proposal and will not be restated here.
The public comment period for our
proposed action closed on October 4,
PO 00000
Frm 00016
Fmt 4700
Sfmt 4700
*
*
*
*
2021. We received no public comments.
Therefore, we are finalizing our action
as proposed.
II. Final Action
In this final action, the EPA is
approving Alaska’s second 10-year LMP
for Eagle River submitted on November
10, 2020, as satisfying the requirements
of section 175A of the CAA.
III. Statutory and Executive Order
Reviews
Under the CAA, the Administrator is
required to approve a SIP submission
that complies with the provisions of the
CAA and applicable Federal regulations.
42 U.S.C. 7410(k); 40 CFR 52.02(a).
Thus, in reviewing SIP submissions, the
EPA’s role is to approve state choices,
provided that they meet the criteria of
the CAA. Accordingly, this action
merely approves State law as meeting
Federal requirements and does not
impose additional requirements beyond
those imposed by State law. For that
reason, this action:
• Is not a ‘‘significant regulatory
action’’ subject to review by the Office
of Management and Budget under
Executive Orders 12866 (58 FR 51735,
October 4, 1993) and 13563 (76 FR 3821,
January 21, 2011);
• Does not impose an information
collection burden under the provisions
of the Paperwork Reduction Act (44
U.S.C. 3501 et seq.);
• Is certified as not having a
significant economic impact on a
substantial number of small entities
under the Regulatory Flexibility Act (5
U.S.C. 601 et seq.);
• Does not contain any unfunded
mandate or significantly or uniquely
affect small governments, as described
in the Unfunded Mandates Reform Act
of 1995 (Pub. L. 104–4);
• Does not have federalism
implications as specified in Executive
E:\FR\FM\09NOR1.SGM
09NOR1
Agencies
[Federal Register Volume 86, Number 214 (Tuesday, November 9, 2021)]
[Rules and Regulations]
[Pages 62095-62096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24419]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
38 CFR Part 4
RIN 2900-AQ67
Schedule for Rating Disabilities: The Cardiovascular System
AGENCY: Department of Veterans Affairs.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: On September 30, 2021, the Department of Veterans Affairs (VA)
published in the Federal Register a final rule that amended the portion
of the VA Schedule for Rating Disabilities (``VASRD'' or ``rating
schedule'') that addresses the cardiovascular system. This correction
addresses the instructions for evaluating peripheral arterial disease
in the published final rule and corrects another minor technical error.
DATES: This correction is effective November 14, 2021.
FOR FURTHER INFORMATION CONTACT: Gary Reynolds, M.D., VASRD Program
Management Office (210), Compensation Service, Veterans Benefits
Administration, Department of Veterans Affairs, 810 Vermont Avenue NW,
Washington, DC 20420, (202) 461-9700. (This is not a toll-free
telephone number.)
SUPPLEMENTARY INFORMATION: VA is correcting its final rule, ``RIN 2900-
AQ67, Schedule for Rating Disabilities: The Cardiovascular System'',
that was published on September 30, 2021, in the Federal Register at 86
FR 54089. The error is with new Note (2) for diagnostic code (DC) 7114
peripheral arterial disease which fails to identify which of the four
tests are necessary before an evaluation can be assigned. In the
proposed rule, VA identified two major shortcomings in the rating
criteria for DC 7114 that were addressed by creating evaluation
criteria that use the ankle/brachial index (ABI), ankle pressure (AP),
toe pressure (TP) and transcutaneous oximetry
(TcPO2) to describe four different levels of
impairment. See 84 FR 37594, 37599 (Aug. 1, 2019). New Note (2)
instructed raters to select the highest impairment value of ABI, AP,
TP, or TcPO2 for evaluation when rating a
condition under DC 7114. Upon further consideration, we believe the
note could be misconstrued as requiring medical examiners to conduct
all four tests. This is inconsistent with our intent, which was to
provide examiners with multiple options in the event that ABI was
unreliable due to non-compressible arteries. To address this issue, we
are correcting new Note (2) to read, ``If AP, TP, and
TcPO2 testing are not of record, evaluate based
on ABI unless the examiner states that an AP, TP, or
TcPO2 test is needed in a particular case because
ABI does not sufficiently reflect the severity of the veteran's
peripheral arterial disease. In all other cases, evaluate based on the
test that provides the highest impairment value.'' This correction
serves two purposes: (1) It reflects VA's intent that although ABI
should be the primary testing by which conditions should be rated under
DC 7114, raters should request AP, TP, or TcPO2
testing when the record reflects that an examiner believes ABI testing
does not sufficiently reflect a veteran's level of impairment, and (2)
when multiple tests are of record, it allows the rater to select the
test result that would grant the veteran the highest evaluation.
Additionally, VA is fixing a technical error with the section
heading for 38 CFR 4.100 to ensure that it is applicable to all
diagnostic codes that could use the general rating formula for diseases
of the heart in its evaluation criteria, such as DCs 7009 and 7110.
Correction
In FR Rule Doc. No. 2021-19998, published September 30, 2021, at 86
FR 54089, make the following corrections:
Sec. 4.100 [Corrected]
0
1. On page 54093, at the top of the third column, remove the section
heading ``Sec. 4.100 Application of the evaluation criteria for
diagnostic codes 7000-7007, 7011, and 7015-7020.'' and add in its place
``Sec. 4.100 Application of the general rating formula for diseases of
the heart.''
0
2. On page 54095, in Sec. 4.104, correct Note (2) in the entry for
diagnostic code 7114 ``Peripheral arterial disease'' to read as
follows:
[[Page 62096]]
Sec. 4.104 Schedule of ratings--cardiovascular system.
* * * * *
Diseases of the Heart
------------------------------------------------------------------------
Rating
------------------------------------------------------------------------
* * * * * * *
7114 Peripheral arterial disease:
* * * * * * *
Note (2): If AP, TP, and TcPO2 testing are not of
record, evaluate based on ABI unless the examiner
states that an AP, TP, or TcPO2 test is needed in a
particular case because ABI does not sufficiently
reflect the severity of the veteran's peripheral
arterial disease. In all other cases, evaluate based on
the test that provides the highest impairment value....
* * * * * * *
------------------------------------------------------------------------
Jeffrey M. Martin,
Assistant Director, Office of Regulation Policy & Management, Office of
the Secretary, Department of Veterans Affairs.
[FR Doc. 2021-24419 Filed 11-8-21; 8:45 am]
BILLING CODE 8320-01-P